These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 7025208)

  • 21. Two monoclonal antibodies identifying a subset of human peripheral mononuclear cells with natural killer cell activity.
    Bai Y; Beverley PC; Knowles RW; Bodmer WF
    Eur J Immunol; 1983 Jul; 13(7):521-7. PubMed ID: 6603362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function.
    Klein M; Roder J; Haliotis T; Korec S; Jett JR; Herberman RB; Katz P; Fauci AS
    J Exp Med; 1980 May; 151(5):1049-58. PubMed ID: 6966316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple functions of natural killer cells, including immunoregulation as well as resistance to tumor growth.
    Herberman RB
    Concepts Immunopathol; 1985; 1():96-132. PubMed ID: 3916408
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunomodulatory effects of interferons on human mononuclear cells with special reference to the expression of cell surface antigens.
    Hokland ME
    Acta Pathol Microbiol Immunol Scand Suppl; 1985; 286():1-35. PubMed ID: 2408439
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunosurveillance and immunotherapy of tumors by innate immune cells.
    Iannello A; Thompson TW; Ardolino M; Marcus A; Raulet DH
    Curr Opin Immunol; 2016 Feb; 38():52-8. PubMed ID: 26686774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor.
    Djeu JY; Blanchard DK
    J Immunol; 1987 Oct; 139(8):2761-7. PubMed ID: 2443572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
    Miescher S; Whiteside TL; Moretta L; von Fliedner V
    J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic reactivity of lymphoid cells in tumors.
    Herberman RB; Holden HT; Varesio L; Taniyama T; Puccetti P; Kirchner H; Gerson J; White S; Keisari Y; Haskill JS
    Contemp Top Immunobiol; 1980; 10():61-78. PubMed ID: 6967800
    [No Abstract]   [Full Text] [Related]  

  • 29. Human NK cells: From surface receptors to clinical applications.
    Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
    Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Natural cellular immunity as the effector mechanism in tumor defense].
    Zielinski C; Müller C
    Acta Med Austriaca; 1987; 14(2):34-6. PubMed ID: 3630578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Life history of cells mediating natural resistance to tumor cells and bone-marrow transplants: the respective roles of cell lineage commitment and host environment in determining strain characteristics of natural resistance to foreign marrow grafts.
    Miller SC
    Am J Anat; 1984 Jul; 170(3):367-76. PubMed ID: 6383004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview and perspectives: natural resistance mechanisms.
    Herberman RB
    Adv Exp Med Biol; 1982; 155():799-808. PubMed ID: 6984287
    [No Abstract]   [Full Text] [Related]  

  • 33. Interactions between NK cells and B lymphocytes.
    Yuan D
    Adv Immunol; 2004; 84():1-42. PubMed ID: 15246249
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cytolytic activity of macrophages and T-lymphocytes in regard to tumor cells in the presence of normal tissue cells].
    Lavrovskiĭ VA; Dobrunova EP
    Eksp Onkol; 1990; 12(4):77-8. PubMed ID: 2379495
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hodgkin's disease--immunological aspects].
    Plat M; Frank KH; Fleischer J; Plat U; Koslowski R
    Allerg Immunol (Leipz); 1988; 34(3):139-58. PubMed ID: 3057835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Innate nonspecific antiviral immunity].
    Błach-Olszewska Z
    Postepy Hig Med Dosw; 1999; 53(1):3-21. PubMed ID: 10352544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of innate immune cells to pathogenesis of severe influenza virus infection.
    Cole SL; Ho LP
    Clin Sci (Lond); 2017 Feb; 131(4):269-283. PubMed ID: 28108632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Immune Cells Migrating to the Ischemic Brain.
    Planas AM
    Stroke; 2018 Sep; 49(9):2261-2267. PubMed ID: 30355002
    [No Abstract]   [Full Text] [Related]  

  • 39. Bacillus Calmette-Guérin as an anti-tumor agent. The interaction with cells of the mammalian immune system.
    Davies M
    Biochim Biophys Acta; 1982 Apr; 651(2-3):143-74. PubMed ID: 7046801
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes.
    Zarling JM; Kung PC
    Nature; 1980 Nov; 288(5789):394-6. PubMed ID: 6968872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.